GASTALDELLI, AMALIA
 Distribuzione geografica
Continente #
NA - Nord America 1.445
AS - Asia 879
EU - Europa 479
SA - Sud America 104
AF - Africa 49
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.960
Nazione #
US - Stati Uniti d'America 1.397
SG - Singapore 307
CN - Cina 230
HK - Hong Kong 119
VN - Vietnam 115
IT - Italia 104
SE - Svezia 94
BR - Brasile 82
GB - Regno Unito 48
DE - Germania 43
AT - Austria 39
FR - Francia 38
BG - Bulgaria 33
CA - Canada 31
CI - Costa d'Avorio 19
JP - Giappone 18
FI - Finlandia 17
IN - India 17
RU - Federazione Russa 17
TR - Turchia 15
MX - Messico 9
ES - Italia 8
NL - Olanda 8
PL - Polonia 8
AR - Argentina 7
BD - Bangladesh 7
IQ - Iraq 7
SA - Arabia Saudita 7
SN - Senegal 6
VE - Venezuela 6
ZA - Sudafrica 6
ID - Indonesia 5
IE - Irlanda 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
NG - Nigeria 4
UZ - Uzbekistan 4
AU - Australia 3
CO - Colombia 3
LT - Lituania 3
NO - Norvegia 3
AZ - Azerbaigian 2
BB - Barbados 2
EC - Ecuador 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
KR - Corea 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
UA - Ucraina 2
AL - Albania 1
BE - Belgio 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
JE - Jersey 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
TG - Togo 1
TN - Tunisia 1
UY - Uruguay 1
Totale 2.960
Città #
Singapore 169
Ashburn 162
Woodbridge 128
Hong Kong 118
San Jose 102
Ann Arbor 91
Santa Clara 88
Fairfield 87
Dallas 79
Chandler 62
Houston 54
Beijing 52
New York 46
Shanghai 46
Seattle 45
Cambridge 37
Serra 36
Ho Chi Minh City 35
Wilmington 35
Sofia 33
Los Angeles 31
Vienna 31
Florence 21
Abidjan 19
Frankfurt am Main 19
Hanoi 19
Boardman 17
London 17
Munich 17
Ottawa 17
Tokyo 17
Princeton 16
Lancaster 15
Lawrence 14
Buffalo 13
Lauterbourg 12
Marseille 12
Council Bluffs 11
Medford 10
Denver 8
Montreal 8
Boulder 7
Helsinki 7
Redondo Beach 7
San Diego 7
Warsaw 7
Dakar 6
Guangzhou 6
Istanbul 6
Orem 6
Atlanta 5
Chicago 5
Des Moines 5
Dublin 5
Haiphong 5
Johannesburg 5
Mumbai 5
Paris 5
Pisa 5
Redwood City 5
San Francisco 5
Amsterdam 4
Brooklyn 4
Da Nang 4
Dong Ket 4
Ha Long 4
Izmir 4
Mexico City 4
Wuhan 4
Baghdad 3
Baltimore 3
Barquisimeto 3
Biên Hòa 3
Brasília 3
Changsha 3
Curitiba 3
Dearborn 3
Fuzhou 3
Hebei 3
Lagos 3
Manchester 3
Norwalk 3
Ogden 3
Phoenix 3
Poplar 3
Quận Một 3
Rio de Janeiro 3
Stockholm 3
Tashkent 3
Turku 3
Addis Ababa 2
Aracaju 2
Baku 2
Basra 2
Belo Horizonte 2
Bremen 2
Bridgetown 2
Carapicuíba 2
Chennai 2
Damietta 2
Totale 2.078
Nome #
Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up 252
Neurophysiological and Behavioural Variables in Cognitive Impairment: Towards a Personalised Monitoring System 190
Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research 183
Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System 176
Insulin resistance and endothelial dysfunction: A mutual relationship in cardiometabolic risk 171
The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF 166
Ectopic fat: The true culprit linking obesity and cardiovascular disease? 163
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies 158
Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study 149
Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma 141
SGLT2 inhibitors and thiazide enhance excretion of DEHP toxic metabolites in subjects with type 2 diabetes: A randomized clinical trial 131
Healthy aging: the INTECMAN project 122
New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms 115
Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion 106
High exposure to phthalates is associated with HbA1c worsening in type 2 diabetes subjects with and without edentulism: a prospective pilot study 87
Brain histone beta-hydroxybutyrylation couples metabolism with gene expression 81
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 79
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis 56
Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases 56
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms 54
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD 50
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 44
The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases 43
In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease 27
LIPIDOMICS REVEALS THAT LOW PLASMA UNSATURATED TO SATURATED FAT RATIOS ARE BIOMARKERS OF NAFLD AND LIVER DAMAGE 26
ADIPOSE TISSUE INSULIN RESISTANCE IS ASSOCIATED WITH MACROPHAGE ACTIVATION IN NON-DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 24
Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms 21
ANGIOPOIETIN-LIKE4 IS ASSOCIATED WITH LIPID METABOLISM AND SEVERE FIBROSIS IN NON-DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 21
DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 20
Correction to: Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease: Steatohepatitis/Metabolic Liver Disease (Hepatology, (2016), 63, 1, (107-116), 10.1002/hep.28287) 19
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile 18
GUT-LIVER AXIS DERANGEMENT DUE TO LACK OF INFLAMMASOME ACTIVITY LEADS TO VISCERAL OBESITY AND NASH DEVELOPMENT 17
Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease 16
Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (Scientific Reports, (2017), 7, 1, (12200), 10.1038/s41598-017-11744-6) 15
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 14
Succinate Modulation as a Biochemical Correlate of Metabolic and Neurobehavioral Changes Associated With Intermittent Fasting in Obesity 9
Totale 3.020
Categoria #
all - tutte 8.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 14 16
2021/2022171 2 5 11 15 27 29 3 8 9 7 10 45
2022/2023306 32 68 23 14 20 28 4 25 62 2 25 3
2023/2024127 8 14 13 2 9 36 12 7 2 3 6 15
2024/2025623 0 18 12 31 57 54 38 50 77 78 59 149
2025/20261.124 49 130 93 153 161 104 160 77 80 115 2 0
Totale 3.020